GH vs MS · rev $739.0M vs P/E 20, $344.27B cap
Guardant Health Inc (GH) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Guardant Health Inc (GH) is a diagnostics & research company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported GH revenue for 2024-12-31 was $739.0M. Net income was -$436.4M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. GH currently screens at market cap $6.32B.
MS does not have a complete income-statement cache yet.
GH currently screens at market cap $6.32B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the GH and MS stock pages for the full models.
Not investment advice.